
-
Simeone backs Atletico to hurt 'extraordinary' Liverpool
-
IEA says more oil and gas investment may be needed
-
Sabrina Carpenter, Justin Bieber, Karol G to headline Coachella
-
Colombia halts US arms purchases in row over drug fight delisting
-
Nestle says chairman Paul Bulcke to step down
-
Isak set for Liverpool debut in Atletico Madrid Champions League clash
-
Malawi votes in economic gloom as two presidents battle for power
-
No info in files that Epstein trafficked women to others: FBI chief
-
Stocks slip, dollar down as Fed meets on rates
-
Faith Kipyegon: Supreme Kenyan champion and role model for mothers
-
Hollywood giants sue Chinese AI firm over copyright infringement
-
Bayern's Kane keen to rekindle London rivalry against Chelsea
-
Trump sues NYT for $15 bn in latest attack on media
-
IndyCar reveals 17-race 2026 season with March opening
-
Trump heads for landmark state visit with 'friend' King Charles
-
Kipyegon sparkles, Tinch's time away pays off with world gold
-
Kerr completes Kiwi world double after Beamish tonic
-
US Fed opens key meeting after Trump aide sworn in as governor
-
Tinch crowns atypical path to top with world hurdles gold
-
Masters deal with Amazon Prime boosts US TV coverage hours
-
Thyssenkrupp says India's Jindal Steel makes bid for steel business
-
Germans turn to health apps as insurers foot the bill
-
Robert Redford, Hollywood's golden boy with a Midas touch
-
US retail sales beat expectations in August despite tariffs
-
New Zealand's Kerr wins world men's high jump gold
-
American Cordell Tinch wins world 110m hurdles gold
-
Kenya's Kipyegon wins unprecedented fourth women's world 1,500m title
-
Suspect in Kirk killing to be charged in US court
-
Cinema legend Robert Redford dead at 89
-
Europe slow to match economic rivals US, China: Draghi
-
Rugby World Cup chiefs defend handling of Berthoumieu biting incident
-
'Like failing a math test': US teen Lutkenhaus schooled at worlds
-
Philippines says one injured in China Coast Guard water cannon attack
-
Kenya court seeks UK citizen's arrest over young mother's murder
-
Malawi votes for a new president as economic crisis bites
-
Barca to stay at Johan Cruyff stadium for Getafe clash
-
'We pulled the children out in pieces': Israel pummels Gaza City
-
Stocks diverge, dollar down as Fed meets on rates
-
Zandvoort, Singapore to host F1 sprints for first time in 2026
-
Afghan man gets life in prison for jihadist knife killing in Germany
-
Shipowner linked to giant Beirut port blast held in Bulgaria
-
E. Timor police clash with protesters over plan to buy vehicles for MPs
-
Israel launches ground assault on Gaza City
-
Malawi votes in battle of two presidents as economic crisis bites
-
2025 summer was Spain's warmest on record: weather agency
-
Gout of this world? Australian teen sprinter set for first real test
-
Smoke-dried bodies could be world's 'oldest mummies': study
-
Afghan gets life in prison for jihadist knife murder in Germany
-
Trump bringing $15 bn lawsuit against New York Times
-
Juan Mata moves to Melbourne from Australian rivals
GSK | -0.37% | 40.15 | $ | |
JRI | -0.61% | 13.975 | $ | |
AZN | -0.22% | 77.877 | $ | |
SCS | -0.54% | 16.78 | $ | |
CMSD | 0.2% | 24.5 | $ | |
BCE | -1.65% | 23.305 | $ | |
RBGPF | 0% | 77.27 | $ | |
RELX | -0.35% | 46.695 | $ | |
BTI | -0.08% | 55.985 | $ | |
RIO | -0.37% | 63.485 | $ | |
VOD | -0.47% | 11.755 | $ | |
BP | 0.74% | 34.465 | $ | |
CMSC | 0.25% | 24.382 | $ | |
NGG | -0.65% | 71.161 | $ | |
RYCEF | -0.06% | 15.63 | $ | |
BCC | -4.13% | 81.745 | $ |

French inventor of abortion pill calls Wyoming ban 'scandalous'
French scientist Etienne-Emile Baulieu, known as the father of the abortion pill, said it was "scandalous" and "a setback for women's freedom" that the US state of Wyoming has banned the drug.
Baulieu, who at the age of 96 is still working on treatments for depression and Alzheimer's, did not mince his words about the ban.
"It is a setback for women's freedom, particularly for those in the most precarious position who do not have the means to go to another state" to get an abortion, he told AFP in an interview.
Last week Wyoming became the first US state to outlaw the use of the abortion pill.
It was the latest point marked for conservative anti-abortion activists in the United States after the Supreme Court overturned the constitutional right to the procedure last year, leaving the policy to individual states.
Baulieu said he had dedicated a large part of his life to "increasing the freedom of women," and the ban was a step in the opposite direction.
Born in Strasbourg in 1926 to Jewish parents, Baulieu was raised by his feminist mother after his father, a doctor, died when he was a boy. At the age of 15, Baulieu joined the French resistance against Nazi occupation.
He went on to become a self-described "doctor who does science," specialising in the field of steroid hormones.
Invited to work in the United States, Baulieu was noticed in 1961 by Gregory Pincus, known as the father of the contraceptive pill, who convinced him to focus on sex hormones.
Back in France, Baulieu designed a way to block the effect of the hormone progesterone, which is essential for the egg to implant in the uterus after fertilisation.
"I wanted to make a contragestive," which stops gestation, he told AFP.
Partnering with the French Roussel-Uclaf laboratory, the oral drug RU-486, also known as mifepristone, was developed in 1982, providing a safe and inexpensive alternative to surgical abortion.
But there was a long battle for the drug to become authorised in the United States, where anti-abortion activists dubbed it the "death pill".
- 'Fanaticism and ignorance' -
In early March, French President Emmanuel Macron praised Baulieu's resilience when he presented the scientist with the Grand-Croix de la Legion d'Honneur, the top rank in France's honours system.
"You, a Jew and a resistance fighter, you were overwhelmed with the most atrocious insults and even compared to Nazi scientists," Macron said.
"But you held on, for the love of freedom and science."
Baulieu's wife Simone Harari Baulieu, a media producer in France, said "adversity slides off him like water off a duck's back".
She added that the recent "step backwards" in the United States was propelled by "fanaticism and ignorance".
Even at age 96, Baulieu heads into his office at the Kremlin-Bicetre University Hospital in the southern suburbs of Paris three times a week.
Stacks of photos, diplomas and binders contain "the work of a lifetime," the scientist said, adding that he still wants to "be useful".
His latest award is pinned to his blue suit, but Baulieu said he "never seriously hoped to receive such honours".
"It was a pleasure, but what interests me is improving people's health."
- 'Driving force' -
The team in his lab are continuing research he began years ago aiming to prevent the development of Alzheimer's disease, as well as treatment for severe depression, for which clinical trials begin in the coming months.
Baulieu said "there is no reason we cannot find treatments" for both illnesses, which have stubbornly evaded many previous attempts.
Julien Giustiniani, the team leader at the Baulieu Institute, which was created to finance research into dementia, said Baulieu was "always enthusiastic".
"He is a driving force for us," Giustiniani said.
Though Baulieu now uses a cane to walk, he exudes a tireless energy.
He partly credits using DHEA, a natural hormone produced by the adrenal gland, which Baulieu first described in the 1960s and has been touted as an anti-ageing supplement.
The causes that have dominated his life were "women, brain health and longevity," Baulieu said.
"I would be bored if I did not work anymore," he added.
X.Karnes--AMWN